Patents by Inventor Anthony R. Reinhold

Anthony R. Reinhold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7056922
    Abstract: A compound of the formula wherein D, E, F, G, L, T, W, X, Y, Z, U, A, R1, R2, R3, R4, R5, R6 R7 are as defined in the specification, pharmaceutical compositions thereof, and methods of use to treat diseases and as D3 receptor modulators.
    Type: Grant
    Filed: July 29, 2003
    Date of Patent: June 6, 2006
    Assignee: Pfizer Inc
    Inventors: Anton F. J. Fliri, Anthony R. Reinhold
  • Patent number: 6921764
    Abstract: The present invention relates to novel quinazolin-4-one derivatives of the formula I, as defined in the specification, pharmaceutical compositions containing such compounds the use of such compounds to treat neurodegenerative, psychotropic, and drug and alcohol induced central and peripheral nervous system disorders.
    Type: Grant
    Filed: August 13, 2003
    Date of Patent: July 26, 2005
    Assignee: Pfizer Inc.
    Inventors: Bertrand L Chenard, Willard M Welch, Anthony R. Reinhold
  • Publication number: 20040049039
    Abstract: The present invention relates to novel quinazolin-4-one derivatives of the formula I, as defined in the specification, pharmaceutical compositions containing such compounds the use of such compounds to treat neurodegenerative, psychotropic, and drug and alcohol induced central and peripheral nervous system disorders.
    Type: Application
    Filed: August 13, 2003
    Publication date: March 11, 2004
    Applicant: Pfizer Inc
    Inventors: Bertrand L. Chenard, Willard M. Welch, Anthony R. Reinhold
  • Publication number: 20040029876
    Abstract: This invention relates to novel acylamino cyclopropane derivatives, processes for their preparation, pharmaceutical compositions containing them and their use as modulators of dopamine D3 receptors and for the treatment of anxiety, psychosis, substance abuse, Parkinson's disease, sexual dysfunction, and other central nervous system disorders.
    Type: Application
    Filed: July 29, 2003
    Publication date: February 12, 2004
    Applicant: Pfizer Inc
    Inventors: Anton F. J. Fliri, Anthony R. Reinhold
  • Patent number: 6627755
    Abstract: The present invention relates to novel quinazolin-4-one derivatives of the formula wherein A is a benzo or thieno fused aromatic ring; B is phenyl, pyridyl or pyrimidyl; X is N or CH; and Y-Z is —CH2NH— or —NHCH2—; and to pharmaceutical compositions containing such compounds, and the use of such compounds to treat neurodegenerative, psychotropic, and drug and alcohol induced central and peripheral nervous system disorders.
    Type: Grant
    Filed: May 14, 1998
    Date of Patent: September 30, 2003
    Assignee: Pfizer INC
    Inventors: Bertrand L. Chenard, Willard M. Welch, Anthony R. Reinhold
  • Publication number: 20020103198
    Abstract: This invention relates to novel acylamino cyclopropane derivatives, processes for their preparation, pharmaceutical compositions containing them and their use as modulators of dopamine D3 receptors and for the treatment of anxiety, psychosis, substance abuse, Parkinson's disease, sexual dysfunction, and other central nervous system disorders.
    Type: Application
    Filed: October 9, 2001
    Publication date: August 1, 2002
    Inventors: Anton F.J Fliri, Anthony R. Reinhold
  • Patent number: 5125102
    Abstract: A digitally trunked radio repeater system provides substantial improvements in timeliness of channel acquisition and channel drop, and in reliability of critical control signalling. The system uses a much higher digital signalling rate than is typically found in prior art systems, and uses a control channel to convey digital channel request and assignment messages between the central site and mobile transceivers. The mobile radio transceivers transmit channel requests on the control channel (if no response is received, the mobile retries during a retry time window which increases in duration in dependence on the number of retries). The mobile transceiver switches to a working channel in response to an assignement message received on the control channel. Subaudible digital signals transmitted on the control channel and on active working channels allow late entry, shifting to higher priority calls, and other advanced functions.
    Type: Grant
    Filed: January 3, 1990
    Date of Patent: June 23, 1992
    Assignee: Ericsson GE Mobile Communications Inc.
    Inventors: Jeffrey S. Childress, Marc A. Dissosway, Gerald M. Cooper, Houston H. Hughes, III